Thiopurine Metabolic Monitoring Leads to Higher Remission of IBD - MD Magazine

Repeated metabolite monitoring with subsequent dose optimization resulted in 67.2% of patients achieving therapeutic levels after 1 year and 87.8% of patients achieving steroid-free remission, while 90% had no therapy escalation or surgery.

New research shows a clear therapeutic benefit for thiopurine metabolic monitoring for patients with inflammatory bowel disease (IBD). A team of investigators, led by Jia Qi Yeo, National Healthcare… [+3203 chars]

full article...